SKVARKA JAN received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/18/2026ACC: 0001838042-26-000003
Director
Since Sep 2022
+57.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
57.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+57.10K
Price / share
—
Trade value
—
% of position
27.6%
6/16/2026
207.15K→264.25K
Total
Net shares
+57.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2026 | A · Award | +57.10K | — | — | 27.6% | 207.15K | 264.25K |
| Total | +57.10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported